These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 31585024)

  • 21. Identification of Compounds That Promote Readthrough of Premature Termination Codons in the CFTR.
    Smith E; Dukovski D; Shumate J; Scampavia L; Miller JP; Spicer TP
    SLAS Discov; 2021 Feb; 26(2):205-215. PubMed ID: 33016182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PTC124 is an orally bioavailable compound that promotes suppression of the human CFTR-G542X nonsense allele in a CF mouse model.
    Du M; Liu X; Welch EM; Hirawat S; Peltz SW; Bedwell DM
    Proc Natl Acad Sci U S A; 2008 Feb; 105(6):2064-9. PubMed ID: 18272502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Downstream Alternate Start Site Allows N-Terminal Nonsense Variants to Escape NMD and Results in Functional Recovery by Readthrough and Modulator Combination.
    Bowling A; Eastman A; Merlo C; Lin G; West N; Patel S; Cutting G; Sharma N
    J Pers Med; 2022 Sep; 12(9):. PubMed ID: 36143233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro prediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis: a pilot study.
    Sermet-Gaudelus I; Renouil M; Fajac A; Bidou L; Parbaille B; Pierrot S; Davy N; Bismuth E; Reinert P; Lenoir G; Lesure JF; Rousset JP; Edelman A
    BMC Med; 2007 Mar; 5():5. PubMed ID: 17394637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Restoration of W1282X CFTR activity by enhanced expression.
    Rowe SM; Varga K; Rab A; Bebok Z; Byram K; Li Y; Sorscher EJ; Clancy JP
    Am J Respir Cell Mol Biol; 2007 Sep; 37(3):347-56. PubMed ID: 17541014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive Analysis of Combinatorial Pharmacological Treatments to Correct Nonsense Mutations in the CFTR Gene.
    Venturini A; Borrelli A; Musante I; Scudieri P; Capurro V; Renda M; Pedemonte N; Galietta LJV
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tobramycin is a suppressor of premature termination codons.
    Altamura N; Castaldo R; Finotti A; Breveglieri G; Salvatori F; Zuccato C; Gambari R; Panin GC; Borgatti M
    J Cyst Fibros; 2013 Dec; 12(6):806-11. PubMed ID: 23540394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Site-Specific RNA Editing of Stop Mutations in the CFTR mRNA of Human Bronchial Cultured Cells.
    Chiavetta RF; Titoli S; Barra V; Cancemi P; Melfi R; Di Leonardo A
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A G542X cystic fibrosis mouse model for examining nonsense mutation directed therapies.
    McHugh DR; Steele MS; Valerio DM; Miron A; Mann RJ; LePage DF; Conlon RA; Cotton CU; Drumm ML; Hodges CA
    PLoS One; 2018; 13(6):e0199573. PubMed ID: 29924856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonsense-mediated RNA Decay Pathway Inhibition Restores Expression and Function of W1282X CFTR.
    Keenan MM; Huang L; Jordan NJ; Wong E; Cheng Y; Valley HC; Mahiou J; Liang F; Bihler H; Mense M; Guo S; Monia BP
    Am J Respir Cell Mol Biol; 2019 Sep; 61(3):290-300. PubMed ID: 30836009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Robust Stimulation of W1282X-CFTR Channel Activity by a Combination of Allosteric Modulators.
    Wang W; Hong JS; Rab A; Sorscher EJ; Kirk KL
    PLoS One; 2016; 11(3):e0152232. PubMed ID: 27007499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations.
    Wilschanski M; Yahav Y; Yaacov Y; Blau H; Bentur L; Rivlin J; Aviram M; Bdolah-Abram T; Bebok Z; Shushi L; Kerem B; Kerem E
    N Engl J Med; 2003 Oct; 349(15):1433-41. PubMed ID: 14534336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Capitalizing on the heterogeneous effects of CFTR nonsense and frameshift variants to inform therapeutic strategy for cystic fibrosis.
    Sharma N; Evans TA; Pellicore MJ; Davis E; Aksit MA; McCague AF; Joynt AT; Lu Z; Han ST; Anzmann AF; Lam AN; Thaxton A; West N; Merlo C; Gottschalk LB; Raraigh KS; Sosnay PR; Cotton CU; Cutting GR
    PLoS Genet; 2018 Nov; 14(11):e1007723. PubMed ID: 30444886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of adenine base editing and homology-independent targeted integration strategies to correct the cystic fibrosis causing variant, W1282X.
    Mention K; Cavusoglu-Doran K; Joynt AT; Santos L; Sanz D; Eastman AC; Merlo C; Langfelder-Schwind E; Scallan MF; Farinha CM; Cutting GR; Sharma N; Harrison PT
    Hum Mol Genet; 2023 Nov; 32(23):3237-3248. PubMed ID: 37649273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene-specific nonsense-mediated mRNA decay targeting for cystic fibrosis therapy.
    Kim YJ; Nomakuchi T; Papaleonidopoulou F; Yang L; Zhang Q; Krainer AR
    Nat Commun; 2022 May; 13(1):2978. PubMed ID: 35624092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological induction of CFTR function in patients with cystic fibrosis: mutation-specific therapy.
    Kerem E
    Pediatr Pulmonol; 2005 Sep; 40(3):183-96. PubMed ID: 15880796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Premature translation termination mutations are efficiently suppressed in a highly conserved region of yeast Ste6p, a member of the ATP-binding cassette (ABC) transporter family.
    Fearon K; McClendon V; Bonetti B; Bedwell DM
    J Biol Chem; 1994 Jul; 269(27):17802-8. PubMed ID: 7517933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergy between Readthrough and Nonsense Mediated Decay Inhibition in a Murine Model of Cystic Fibrosis Nonsense Mutations.
    McHugh DR; Cotton CU; Hodges CA
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficient suppression of endogenous CFTR nonsense mutations using anticodon-engineered transfer RNAs.
    Ko W; Porter JJ; Sipple MT; Edwards KM; Lueck JD
    Mol Ther Nucleic Acids; 2022 Jun; 28():685-701. PubMed ID: 35664697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional rescue of c.3846G>A (W1282X) in patient-derived nasal cultures achieved by inhibition of nonsense mediated decay and protein modulators with complementary mechanisms of action.
    Laselva O; Eckford PD; Bartlett C; Ouyang H; Gunawardena TN; Gonska T; Moraes TJ; Bear CE
    J Cyst Fibros; 2020 Sep; 19(5):717-727. PubMed ID: 31831337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.